Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma

• Robert J. Torphy,

  Affiliation University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

  ⨯
• Christopher J. Tignanelli,

  Affiliation Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Joyce W. Kamande,

  Affiliation Department of Chemistry, Louisiana State University, Baton Rouge, Louisiana, United States of America

  ⨯
• Richard A. Moffitt,

  Affiliation Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Silvia G. Herrera Loeza,

  Affiliation Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Steven A. Soper,

  Affiliations Department of Biomedical Engineering, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Jen Jen Yeh

  * E-mail: jjyeh@med.unc.edu

  Affiliations University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, United States of America, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America, Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯